Loading…
Operates in Healthcare Services — General medicine - private practice. Per the activity note to the FY2024 annual report, the company operates as an endocrinology national institute providing general medical practice.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 4,131 | 4,782 | 5,454 | 8,331 | 9,911 | 14,193 | 15,944 | +25.2% | |
| Total COGS | 545 | 694 | 746 | 1,290 | 1,297 | 1,530 | 2,048 | +24.7% |
| Gross Profit | 3,586 | 4,088 | 4,707 | 7,041 | 8,614 | 12,663 | 13,896 | +25.3% |
| Gross Margin | 86.8% | 85.5% | 86.3% | 84.5% | 86.9% | 89.2% | 87.2% | |
| 2,630 | 3,228 | 3,547 | 5,458 | 6,469 | 9,180 | 11,780 | +28.4% | |
| EBITDA | 956 | 860 | 1,160 | 1,583 | 2,145 | 3,484 | 2,116 | +14.2% |
| EBITDA Margin | 23.1% | 18.0% | 21.3% | 19.0% | 21.6% | 24.5% | 13.3% | |
| Total D&A | 133 | 168 | 198 | 250 | 381 | 536 | 335 | +16.7% |
| EBIT / Operating Income | 823 | 692 | 961 | 1,333 | 1,765 | 2,948 | 1,781 | +13.7% |
| Total Interest Expense | 0 | 0 | 0 | 0 | 0 | 102 | 142 | +38.8% |
| 3 | 2 | 0 | 29 | 1 | 3 | 13 | nmf | |
| Profit Before Tax | 820 | 694 | 962 | 1,305 | 1,764 | 2,848 | 1,652 | +12.4% |
| Total Income Tax | 72 | 6 | 52 | 221 | 186 | 257 | 162 | +14.4% |
| Net Profit / (Loss) | 748 | 688 | 910 | 1,084 | 1,578 | 2,591 | 1,490 | +12.2% |
| Net Margin | 18.1% | 14.4% | 16.7% | 13.0% | 15.9% | 18.3% | 9.3% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →